M. Kulyk & Associates, LLC

Position in LLY — ELI LILLY & Co

CIK 1842370 DECATUR, GA

Position in LLY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$9,529,472

+$6,613,802 QoQ

Shares Held

7,945

+150.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.02%

of 13F equity value

Holder Rank

#1,289

of 4,605 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M. Kulyk & Associates, LLC holds $37,765,981 across 8 Drug Manufacturers - General names. LLY ranks #2 (25.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	94,863	$12,189,895
2	LLY	ELI LILLY & Co This page	7,945	$9,529,472
3	GILD	Gilead Sciences, Inc.	74,859	$9,457,686
4	NVO	Novo Nordisk A S	93,400	$4,477,596
5	ABBV	AbbVie Inc.	3,846	$967,807
6	JNJ	Johnson & Johnson	1,941	$492,955
7	NVS	Novartis AG	2,439	$382,240
8	AMGN	Amgen Inc	741	$268,330

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,529,472	7,945	+150.6%	Shares	Sole	2026-08-07
2026-03-31	$2,915,670	3,170	+1327.9%	Shares	Sole	2026-05-06
2025-12-31	$238,578	222	-33.3%	Shares	Sole	2026-01-08
2024-09-30	$295,018	333	+0.6%	Shares	Sole	2024-11-07
2024-06-30	$299,680	331	-26.6%	Shares	Sole	2024-08-05
2024-03-31	$350,859	451	-0.4%	Shares	Sole	2024-05-09
2023-12-31	$264,062	453	-1.1%	Shares	Sole	2024-02-13
2023-09-30	$246,005	458	+1.6%	Shares	Sole	2023-11-07
2023-06-30	$211,509	451	-53.5%	Shares	Sole	2023-08-08
2022-09-30	$313,326	969	-24.6%	Shares	Sole	2022-11-07
2022-06-30	$416,635	1,285	0.0%	Shares	Sole	2022-08-05
2022-03-31	$367,985	1,285	+2.0%	Shares	Sole	2022-05-11
2021-12-31	$348,037	1,260	—	Shares	Sole	2022-01-20
No filing history on record for this holder in this stock.